{
    "cancelStatus": "0",
    "licStatus": "1",
    "cancelDate": null,
    "cancelReason": [],
    "otherCancelReason": "",
    "licid": "52026968",
    "licUnit": "1",
    "validDate": "2026-11-10 00:00:00.000",
    "issueDate": "2016-11-10 00:00:00.000",
    "oriIssueDate": null,
    "licKind": "02",
    "oldLicid": null,
    "certNo": "DHA05202696807",
    "prodNameC": "泰格莎膜衣錠80毫克",
    "prodNameE": "TAGRISSO Film-coated Tablets 80 mg",
    "indicationsName": [
        "1. EGFR突變陽性的非小細胞肺癌 (NSCLC) 之輔助治療：適用於腫瘤帶有表皮生長因子受體 (EGFR) 外顯子19缺失或外顯子21 L858R突變之非小細胞肺癌 (NSCLC) 病人，作為腫瘤切除後的輔助治療。\n2. EGFR突變陽性的轉移性NSCLC之第一線治療：適用於腫瘤具表皮生長因子受體 (EGFR) 突變之局部侵犯性或轉移性NSCLC病人的第一線治療。\n3. EGFR 突變陽性的局部晚期或轉移性 NSCLC 之第一線治療：併用 pemetrexed 和含鉑化療，適用於腫瘤帶有 EGFR 外顯子 19 缺失或外顯子 21 L858R 突變之局部晚期或轉移性非小細胞肺癌成人病人，作為第一線治療。\n4. 曾接受治療之EGFR T790M突變陽性的轉移性NSCLC：適用於治療具有EGFR T790M基因突變之局部侵犯性或轉移性NSCLC在EGFR TKI治療期間或之後疾病惡化的病人。"
    ],
    "does": "1116",
    "packageUnit": [
        {
            "packageSpec": "2-1000錠",
            "packageUnit": "89"
        }
    ],
    "medMCode": "06",
    "maMedCode": "",
    "medDCode": null,
    "mainCategory": null,
    "drBaseId": "BEDA6A25-F5D9-40A3-8E61-91F21D40A20E",
    "subCategory": [],
    "ingredientsDesc": [
        "Osimertinib mesylate"
    ],
    "restraintItemsCode": [
        "02",
        "07",
        "1S",
        "5F"
    ],
    "applicantName": "臺灣阿斯特捷利康股份有限公司",
    "applicantAddr": "台北市大安區敦化南路二段207號21樓",
    "medClass": null,
    "efficacy": " ",
    "mdFormat": null,
    "productAnnotation": "",
    "mdKind": [],
    "monitorDate": "2021-11-10",
    "licidNew": null,
    "licidOld": null,
    "factoryDtoList": [
        {
            "id": "D2ABA964-6D59-485A-ADDE-FBB802076CA9",
            "factoryCode": "1",
            "factoryName": "ASTRAZENECA AB",
            "factoryAddr": "SE-151 85 SODERTALJE SWEDEN",
            "factoryCompanyAddr": null,
            "countryCode": "SE",
            "processCode": [],
            "processCodeStr": null,
            "factoryKind": "M",
            "factoryNo": "FSE0032000",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": "9200082310",
            "ingredientsName": "Osimertinib mesylate",
            "ingredientsDesc": "Osimertinib mesylate",
            "concentDesc": "(1.192mg of osimertinib mesylate is equivalent to 1 mg of osimertinib freebase)",
            "concent": "95.4000",
            "concentUnit": "001",
            "seq": "1",
            "prescription_seq": "1",
            "prescription_Kind": "1"
        }
    ],
    "authDtoList": [],
    "iomDtoList": [],
    "changeDtoList": [],
    "atcList": [
        {
            "isMain": "1",
            "atcCode": "L01EB04"
        }
    ],
    "licBaseId": "ED75F15A-2F02-4EB2-9342-16698AF3D7CD"
}